Greenwich LifeSciences, Inc.

NASDAQ:GLSI

14.17 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Assets:
Current Assets:
Cash & Cash Equivalents 6.98913.46827.20428.660.0070.0850
Short Term Investments 0000000
Cash and Short Term Investments 6.98913.46827.20428.660.0070.0850
Net Receivables 0000000
Inventory 0000000
Other Current Assets 0000000
Total Current Assets 6.98913.46827.20428.660.0070.0850
Non-Current Assets:
Property, Plant & Equipment, Net 0000000
Goodwill 0000000
Intangible Assets 0.0050.0090.0130.0160.020.0230
Goodwill and Intangible Assets 0.0050.0090.0130.0160.020.0230
Long Term Investments 0000000
Tax Assets 0000000
Other Non-Current Assets 0000000
Total Non-Current Assets 0.0050.0090.0130.0160.020.0230.027
Total Assets 6.99513.47727.21728.6770.0270.1090.027
Liabilities & Equity:
Current Liabilities:
Account Payables 0.03500.2210.7110.730.2780.161
Short Term Debt 00000.0010.420
Tax Payables 0000000
Deferred Revenue 000-0-0.001-0.420
Other Current Liabilities 0.2590.2630.1640.3350.6470.4510.396
Total Current Liabilities 0.2940.2630.3851.0451.3770.7290.558
Non-Current Liabilities:
Long Term Debt 0000000
Deferred Revenue Non-Current 0000000
Deferred Tax Liabilities Non-Current 0000000
Other Non-Current Liabilities 000009.58
Total Non-Current Liabilities 000009.58
Total Liabilities 0.2940.2630.3851.0451.37710.2298.558
Equity:
Preferred Stock 00000.0020.0020.005
Common Stock 0.0130.0130.0130.0130.00800.001
Retained Earnings -50.365-41.473-33.648-29.077-27.214-23.789-22.099
Accumulated Other Comprehensive Income/Loss 00-0-000-0.001
Other Total Stockholders Equity 57.05254.67460.46656.69525.85313.66613.563
Total Shareholders Equity 6.713.21426.83227.631-1.35-10.12-8.53
Total Equity 6.713.21426.83227.631-1.35-10.12-8.53
Total Liabilities & Shareholders Equity 6.99513.47727.21728.6770.0270.1090.027